Mendelian randomisation study of smoking exposure in relation to breast cancer risk
Hanla A. Park(German Cancer Research Center), Jürgen Geisler(Oslo University Hospital), Annelie Augustinsson(Lund University), Olav Engebråten(University of Oslo), Marina Bermisheva(Russian Academy of Sciences), Federico Canzian(German Cancer Research Center), Volker Arndt(German Cancer Research Center), Hiltrud Brauch(German Cancer Research Center), Natalia Bogdanova(Medizinische Hochschule Hannover), Jose E. Castelao(Servicio Gallego de Salud), Kristin V. Reinertsen(Oslo University Hospital), Sara Y. Brucker(University Children's Hospital Tübingen), Cecile E. Kiserud(University of Southampton), Heiko Becher(Universität Hamburg), Joe Dennis(University of Cambridge), Kristine Kleivi Sahlberg(University of Oslo), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Matthias W. Beckmann(Universitätsklinikum Erlangen), Thomas U. Ahearn(Harvard University), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Irene L. Andrulis(University of Toronto), Sabine Behrens(German Cancer Research Center), Javier Benı́tez(Spanish National Cancer Research Centre), Christine L. Clarke(Memorial University of Newfoundland), Åslaug Helland(Oslo University Hospital), Alexander Fosså(Oslo University Hospital), Adinda Baten(KU Leuven), Marit Muri Holmen(Unknown), Vilde Drageset Haakensen(University of Oslo), Daniele Campa(University of Pisa), Toril Sauer(Leiden University Medical Center), Stig E. Bojesen(University of Copenhagen), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Lars Ottestad(Norwegian Cancer Society), Sonja Neumeyer(German Cancer Research Center), Laura E. Beane Freeman(National Cancer Institute), Rolf Kåresen(Oslo University Hospital), Kristan J. Aronson(Queen's University), Stephen J. Chanock(National Cancer Institute), Qin Wang(University of Cambridge), Ellen Schlichting(Oslo University Hospital), Barbara Burwinkel(German Cancer Research Center), Natalia Antonenkova(N.N. Alexandrov National Cancer Centre), Anne‐Lise Børresen‐Dale(Oslo University Hospital), Margit Riis(Gentofte Hospital), Manjeet K. Bolla(University of Cambridge), Grethe I.G. Alnæs(Oslo University Hospital), Bjørn Naume(Norwegian Cancer Society)
Cited by 24
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k